CH675831A5 - - Google Patents

Download PDF

Info

Publication number
CH675831A5
CH675831A5 CH3838/87A CH383887A CH675831A5 CH 675831 A5 CH675831 A5 CH 675831A5 CH 3838/87 A CH3838/87 A CH 3838/87A CH 383887 A CH383887 A CH 383887A CH 675831 A5 CH675831 A5 CH 675831A5
Authority
CH
Switzerland
Prior art keywords
asa
hours
dose
day
composition according
Prior art date
Application number
CH3838/87A
Other languages
German (de)
English (en)
Inventor
Henry C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH675831A5 publication Critical patent/CH675831A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH3838/87A 1986-10-09 1987-10-02 CH675831A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CH675831A5 true CH675831A5 (it) 1990-11-15

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3838/87A CH675831A5 (it) 1986-10-09 1987-10-02

Country Status (24)

Country Link
JP (1) JPS63101334A (it)
KR (1) KR880004801A (it)
AU (1) AU7942087A (it)
BE (1) BE1000732A5 (it)
CA (1) CA1332809C (it)
CH (1) CH675831A5 (it)
DE (1) DE3733540A1 (it)
DK (1) DK527487A (it)
ES (1) ES2014518A6 (it)
FI (1) FI874414A (it)
FR (1) FR2604902B1 (it)
GB (2) GB8624213D0 (it)
GR (1) GR871550B (it)
HU (1) HU201875B (it)
IL (1) IL84104A0 (it)
IT (1) IT1221493B (it)
LU (1) LU87009A1 (it)
NL (1) NL8702294A (it)
NO (1) NO874200L (it)
NZ (1) NZ222083A (it)
PH (1) PH24227A (it)
PT (1) PT85880B (it)
SE (1) SE8703889L (it)
ZA (1) ZA877617B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
HU230440B1 (hu) 1999-03-31 2016-06-28 Janssen Pharmaceutica N.V Előgélesített keményítőt tartalmazó szabályozott felszabadulású készítmények
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
JP4814885B2 (ja) * 2004-09-09 2011-11-16 サイコファルマ,エッセ.エ.デ セ.ウヴェ. ヒドララジン持続放出用医薬組成物および該組成物を含む癌治療薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제

Also Published As

Publication number Publication date
GB2195893B (en) 1991-05-08
DK527487D0 (da) 1987-10-08
FR2604902A1 (fr) 1988-04-15
PT85880B (pt) 1990-07-31
DK527487A (da) 1988-04-10
GR871550B (en) 1988-02-15
GB2195893A (en) 1988-04-20
HU201875B (en) 1991-01-28
AU7942087A (en) 1988-04-14
CA1332809C (en) 1994-11-01
GB8624213D0 (en) 1986-11-12
ES2014518A6 (es) 1990-07-16
GB8723515D0 (en) 1987-11-11
IT8748469A0 (it) 1987-10-08
SE8703889L (sv) 1988-04-10
BE1000732A5 (fr) 1989-03-21
KR880004801A (ko) 1988-06-27
JPS63101334A (ja) 1988-05-06
NL8702294A (nl) 1988-05-02
PH24227A (en) 1990-05-04
SE8703889D0 (sv) 1987-10-08
DE3733540A1 (de) 1988-04-14
ZA877617B (en) 1989-05-30
FR2604902B1 (fr) 1991-04-26
LU87009A1 (fr) 1988-05-03
IT1221493B (it) 1990-07-06
HUT52958A (en) 1990-09-28
NO874200L (no) 1988-04-11
FI874414A0 (fi) 1987-10-07
FI874414A (fi) 1988-04-10
PT85880A (en) 1987-11-01
NO874200D0 (no) 1987-10-07
IL84104A0 (en) 1988-03-31
NZ222083A (en) 1991-05-28

Similar Documents

Publication Publication Date Title
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE69730314T2 (de) Dosierungsform von ibuprofen
DE69826290T2 (de) Pharmazeutische zusammensetzungen zur kontrollierten freigabe von wirkstoffen
DE69533492T2 (de) Orale Metoprolol-Dosisform des Typs "einmal täglich"
DE3246492C2 (de) Verfahren zur Herstellung therapeutischer Präparate auf der Basis von Hydroxypropylmethylzellulose mit verlängertem Freisetzungsverlauf
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
EP2477660B1 (de) Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin
DE69829042T2 (de) Nicotinsäurezusammensetzungen enthaltender Starterkit
DE69924987T2 (de) Pharmazeutische Zusammensetzung enthaltend synthetisch natürliches Progesteron und Östradiol und Verfahren zur Herstellung derselben
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
LU84962A1 (de) Naproxen-und naproxen-natrium-tabletten mit kontrollierter wirkstoffreigabe
WO2003030869A1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE2128461A1 (de) Pharmazeutisches Präparat
CH675831A5 (it)
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
DE60225686T2 (de) Paracetamol enthaltende tablette
DE10003757A1 (de) Ibuprofen-Wirkstoffzubereitung
DE60309565T2 (de) Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
DE60320039T2 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
DE1907546A1 (de) Schnell zerfallende feste Dosierungseinheiten
EP2515852B1 (de) Oral dispersible tablette enthaltend kompaktierte sildenafil-base
DE69428455T3 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
DE60117712T2 (de) Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam-antibiotikums
DE3226178A1 (de) Mittel enthaltend n-acetyl-p-aminophenol und ein antacidum

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate filed

Free format text: IKS 51189/940223

SPCF Supplementary protection certificate filed

Free format text: IKS 52189/940223, 951214

SPCR Supplementary protection certificate rejected

Free format text: IKS 51189/940223, 951214

PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased